F
ENTA icon

FolioMetrix’s Enanta Pharmaceuticals ENTA Stock Holding History

FolioMetrix’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,800
Closed -$454K – 240
2014
Q4 		$454K Buy
+10,800
New +$484K 0.32% 71

Other funds holding ENTA

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MVM
McClain Value Management New Canaan, Connecticut $50.9M AUM 16.06% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FolioMetrix's ENTA Position: Q1 2015 in Review

FolioMetrix sold out of Enanta Pharmaceuticals (ENTA) in Q1 2015, closing a stake of 10,800 shares — an estimated $454K sold.

FolioMetrix first reported a position in ENTA in Q4 2014 and held it in 1 quarter. The position peaked at $454K in Q4 2014. 118 funds tracked by Wall St. Rank hold ENTA as of Q1 2015.

  • FolioMetrix reported no remaining Enanta Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • FolioMetrix sold 10,800 Enanta Pharmaceuticals shares in Q1 2015, an estimated $454K.
  • FolioMetrix first reported a position in Enanta Pharmaceuticals in Q4 2014 and held it in 1 quarter.
  • FolioMetrix's Enanta Pharmaceuticals position peaked at $454K in Q4 2014.
  • 118 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2015.

Based on FolioMetrix's 13F filing for Q1 2015, filed 28 Apr 2015.